Full Text View
Tabular View
No Study Results Posted
Related Studies
Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressive Metastatic or Unresectable Colorectal Cancer or Other Solid Tumors
This study is ongoing, but not recruiting participants.
Study NCT00138177   Information provided by Roswell Park Cancer Institute
First Received: August 29, 2005   Last Updated: March 8, 2011   History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study
About Study Results Reporting on ClinicalTrials.gov
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)
Publications:
Fakih MG, Pendyala L, Fetterly G, Toth K, Zwiebel JA, Espinoza-Delgado I, Litwin A, Rustum YM, Ross ME, Holleran JL, Egorin MJ. A phase I, pharmacokinetic and pharmacodynamic study on vorinostat in combination with 5-fluorouracil, leucovorin, and oxaliplatin in patients with refractory colorectal cancer. Clin Cancer Res. 2009 May 1;15(9):3189-95. Epub 2009 Apr 21.
Fakih MG, Pendyala L, Smith P, et al.: A phase I study of vorinostat (suberoylanilide hydroxamic acid) in combination with 5-fluorouracil, leucovorin, and oxaliplatin (FOLFOX) in patients with advanced colorectal cancer (CRC). [Abstract] J Clin Oncol 25 (Suppl 18): A-4088, 185s, 2007.